1. X
  2. Science Translational Medicine
Log inSign up
Science Translational Medicine
3,961 posts
Science Translational Medicine profile banner
user avatar

Science Translational Medicine

@ScienceTM
Science Translational Medicine is the leading weekly online journal publishing translational research at the intersection of science, engineering and medicine.
Washington, DC
science.org/journal/stm
Joined February 2011
273
Following
35K
Followers
RepliesRepliesMediaMedia
  • user avatar
    Science Translational Medicine
    @ScienceTM
    Aug 22
    Using a mosaic nanoparticle platform, researchers interrogate how antigen avidity shapes the durability of responses to HIV vaccines in mice and show that high valency elicits more robust B cell and germinal center responses. @UTMB_Pathology scim.ag/4gtOAly
    Image
  • user avatar
    Science Translational Medicine
    @ScienceTM
    Aug 21
    By analyzing more than 800,000 single-cell profiles in tissues and blood, a team assembles a massive biomolecular compendium of lupus nephritis that maps out its impact on cell populations and could inform future therapeutics. @soumya_boston @BrighamWomens scim.ag/4wDB7MI
    Image
  • user avatar
    Science Translational Medicine
    @ScienceTM
    Aug 20
    By parsing the DNA #fragmentome, a team identifies cell-free DNA signatures that can give early warning during the first trimester of pregnancy complications in women with risk factors such as twinning and autoimmune disease. @CHG_CME @KateEStanley1 scim.ag/3UavEj4
    Image
  • user avatar
    Science Translational Medicine
    @ScienceTM
    Aug 19
    The new issue of #ScienceTranslationalMedicine is out now! The DNA fragmentome can give early warning about pregnancy complications in high-risk patients, a compendium of lupus nephritis reveals how the condition skews cells and tissues, and more. scim.ag/4x6M8HL
    Image
  • user avatar
    Science Translational Medicine
    @ScienceTM
    Aug 18
    Combining mutant #p53 reactivation via arsenic trioxide with the standard therapy decitabine kills acute myeloid leukemia and MDS cells and shows promise in a small pilot trial in patients carrying rescuable p53 mutations. @sjtu1896 scim.ag/4cnWLgN
    Image

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Advertisement
Advertisement